The World Has More GLP-1s but Who Can Afford Them? Part 2

The Plus SideZ: A GLP-1 Guide to Metabolic Health

The Plus SideZ: A GLP-1 Guide to Metabolic Health
The World Has More GLP-1s but Who Can Afford Them? Part 2
Sep 08, 2026 Season 7 Episode 9
Kim Carlos

Linktree - our favorite links (https://linktr.ee/dinosaurmonkeyfarts)

NEW: Need GLP-1 Care? Join me at Belle! Use Podcast at checkout to save!
https://link.joinbelle.com/podcast

NEW: Cozy Butter GLP-1 Community! Join Free (https://cozybutter.com/)
https://cozybutter.com/

A GLP-1 community where support isn’t at the mercy of the algorithm.

  • Live GLP-1 support groups
  • Live support groups and social events
  • Health coaching and expert Q&As
  • Cooking, movement, and stress-management classes
  • GLP-1 tools and guidance (water, protein, side effect management, etc.) 
  • A dedicated community beyond the algorithm

Book at 1 on 1 with Kim (https://calendly.com/theplussidez/kim...)  


The World Has More GLP-1s but Who Can Afford Them? Part 2


This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication.

Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world.

In Part 2, we discuss:

• Managing daily life and side effects on GLP-1 medication
• Why weight loss slows and plateaus happen
• How the body’s set point may affect weight
• What GLP-1 maintenance really means
• Balancing continued weight loss with stabilization
• Adjusting treatment for long-term care
• What Ireland could learn from the U.S. rollout of GLP-1 medications

Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience navigating GLP-1 side effects, plateaus, maintenance and long-term treatment.

CONNECT WITH OUR GUESTS

Dr. Michael “Mick” Crotty

My Best Weight
https://www.mybestweight.ie/

Instagram
https://www.instagram.com/mybestweight.ie/

LinkedIn
https://ie.linkedin.com/in/drmichaelcrotty

Belinda Hogan

Instagram
https://www.instagram.com/mid.life.insights/

The Dose with Paddy and Belinda
https://linktr.ee/TheDosePodcast

SOURCES

Oral Wegovy launches in Germany
https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/

Hims & Hers expands its GLP-1 services into Australia
https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/

600,000 people sign up for the Medicare obesity drug program
https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/

Employer GLP-1 coverage fell in 2026
https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/

PepsiCo and other employers cut GLP-1 coverage
https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790

Medicare enrollment data
https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment



Send us Fan Mail!

Support the show

Kim Carlos, Executive Producer 

TikTok

Instagram 

Kat Carter,  Producer 

TikTok

Instagram 

Episode Artwork The World Has More GLP-1s but Who Can Afford Them? Part 2 57:45 Episode Artwork BIG NEWS! We Deserve Better. So We Built It. 🧈 1:36 Episode Artwork The World Has More GLP-1s but Who Can Afford Them? Part 1 1:01:02 Episode Artwork GLP-1 vs. Big Food: Is the Food Industry Trying to Outsmart the Medications? 1:23:14 Episode Artwork GLP-1s, Bariatric Surgery & the Uncomfortable Truth About Eating Disorders 1:12:46 Episode Artwork GLP-1 & Weight Regain: Why We Blame Ourselves 49:12 Episode Artwork GLP-1 News: New Studies, Lawsuits & Compounding 1:17:50 Episode Artwork GLP-1 Movement vs. Body Positive & Fat Liberation Movements 1:57:26 Episode Artwork Bonus Episode: FAQ Medicare Bridge Program & GLP-1 Coverage 18:47 Episode Artwork How GLP-1s Broke Diet Culture 1:34:49 Episode Artwork Why GLP-1s Work When Diets Don’t | Obesity Doctor Explains 1:30:34 Episode Artwork GLP-1s and Addiction? 1:39:48 Episode Artwork GLP-1 Medicare Coverage FAQ & Weight Loss Tips From Obesity Doctor 1:22:30 Episode Artwork GLP-1 Stall? Why Your Body Stops Losing Weight | Dr. Michelle Gordon 1:04:04 Episode Artwork Debunking the *LIES* About GLP-1s (Ozempic Myths Overruled by Obesity Doctors) 1:28:40 Episode Artwork GLP-1 Over 60: Obesity Doctor Explains Part 2 1:04:31 Episode Artwork GLP-1 Over 60: Why This Feels Different Now Part 1 1:01:21 Episode Artwork GLP-1 & PCOS: Why So Many Women Were Misdiagnosed 1:31:24 Episode Artwork GLP-1s & Rosie O’Donnell: Weight Loss Over 60 1:30:30 Episode Artwork GLP-1 Stopped Working? What’s Really Happening (Replay Dr. Spencer Nadolsky) 1:02:11 Episode Artwork GLP-1: What We’re Not Talking About 56:50 Episode Artwork New to GLP-1s? Start Here | The Truth About Obesity (S1 Ep 5 Repost) 1:06:50 Episode Artwork Do You Have to Exercise on GLP-1? 1:01:54 Episode Artwork GLP-1 vs Diet Culture: Body Positivity and No-Lose Debate 1:08:37 Episode Artwork GLP-1 News Update: Stopping the Meds, What Happens Next & The Future of New Treatments 1:04:25